reference/22222500

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/22222500

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	144
issn	0142-9612
pageRange	131-144
publicationName	Biomaterials
startingPage	131
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6355450fa399697f9298ca6b9ee2e4c9 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_51c549fcc64ee4c9d8d104fb68fb9243
bibliographicCitation	Li K, Liu H, Gao W, Chen M, Zeng Y, Liu J, Xu L, Wu D. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy. Biomaterials. 2015 Jan;39():131–44. doi: 10.1016/j.biomaterials.2014.10.073. PMID: 25477180.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d34e61d66c8a4436ef0b54d80259e394 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_24f564730ab73a6226ad827b9f53bccd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bb530bad5ad88764ee0c10914aa739ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6183-539X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cfa5adb5d6eefc3cc7e9f6f1319265ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_111ff006ec064161697dbf4c5e7c6ea1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d8f6be0b1d23b3bbbc5389c0d9711f2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7c9f075057cc82750f4424639414e85f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4573bf97fd05cce380d8670fb744dbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2343-4998
date	201501
identifier	https://pubmed.ncbi.nlm.nih.gov/25477180 https://doi.org/10.1016/j.biomaterials.2014.10.073
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1138 https://portal.issn.org/resource/ISSN/0142-9612
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy
discusses	http://id.nlm.nih.gov/mesh/M0013754 http://id.nlm.nih.gov/mesh/M0020435 http://id.nlm.nih.gov/mesh/M0528589 http://id.nlm.nih.gov/mesh/M0006784 http://id.nlm.nih.gov/mesh/M0010664 http://id.nlm.nih.gov/mesh/M0009556
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006820Q000737 http://id.nlm.nih.gov/mesh/D053758Q000737 http://id.nlm.nih.gov/mesh/D016503Q000379 http://id.nlm.nih.gov/mesh/D031625 http://id.nlm.nih.gov/mesh/D008823 http://id.nlm.nih.gov/mesh/D006072Q000031 http://id.nlm.nih.gov/mesh/D004317Q000008 http://id.nlm.nih.gov/mesh/D004317Q000737 http://id.nlm.nih.gov/mesh/D013213Q000737
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D006367 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D006072Q000737 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D008807
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135513044

Total number of triples: 54.